195 related articles for article (PubMed ID: 32659405)
1. Nanosuspensions of a poorly soluble investigational molecule ODM-106: Impact of milling bead diameter and stabilizer concentration.
Singhal M; Baumgartner A; Turunen E; van Veen B; Hirvonen J; Peltonen L
Int J Pharm; 2020 Sep; 587():119636. PubMed ID: 32659405
[TBL] [Abstract][Full Text] [Related]
2. A quality-by-design study to develop Nifedipine nanosuspension: examining the relative impact of formulation variables, wet media milling process parameters and excipient variability on drug product quality attributes.
Patel PJ; Gajera BY; Dave RH
Drug Dev Ind Pharm; 2018 Dec; 44(12):1942-1952. PubMed ID: 30027778
[TBL] [Abstract][Full Text] [Related]
3. Miconazole nanosuspensions: Influence of formulation variables on particle size reduction and physical stability.
Cerdeira AM; Mazzotti M; Gander B
Int J Pharm; 2010 Aug; 396(1-2):210-8. PubMed ID: 20600732
[TBL] [Abstract][Full Text] [Related]
4. Food proteins as novel nanosuspension stabilizers for poorly water-soluble drugs.
He W; Lu Y; Qi J; Chen L; Hu F; Wu W
Int J Pharm; 2013 Jan; 441(1-2):269-78. PubMed ID: 23194889
[TBL] [Abstract][Full Text] [Related]
5. Investigation of Formulation and Process Parameters of Wet Media Milling to Develop Etodolac Nanosuspensions.
Karakucuk A; Celebi N
Pharm Res; 2020 May; 37(6):111. PubMed ID: 32476048
[TBL] [Abstract][Full Text] [Related]
6. A comparative study of top-down and bottom-up approaches for the preparation of micro/nanosuspensions.
Verma S; Gokhale R; Burgess DJ
Int J Pharm; 2009 Oct; 380(1-2):216-22. PubMed ID: 19596059
[TBL] [Abstract][Full Text] [Related]
7. Nanosuspensions of poorly soluble drugs: preparation and development by wet milling.
Liu P; Rong X; Laru J; van Veen B; Kiesvaara J; Hirvonen J; Laaksonen T; Peltonen L
Int J Pharm; 2011 Jun; 411(1-2):215-22. PubMed ID: 21458552
[TBL] [Abstract][Full Text] [Related]
8. Fabrication of multicomponent amorphous bufadienolides nanosuspension with wet milling improves dissolution and stability.
Zuo W; Qu W; Li N; Yu R; Hou Y; Liu Y; Gou G; Yang J
Artif Cells Nanomed Biotechnol; 2018 Nov; 46(7):1513-1522. PubMed ID: 28906144
[TBL] [Abstract][Full Text] [Related]
9. Nanosuspension for improving the bioavailability of a poorly soluble drug and screening of stabilizing agents to inhibit crystal growth.
Ghosh I; Bose S; Vippagunta R; Harmon F
Int J Pharm; 2011 May; 409(1-2):260-8. PubMed ID: 21371540
[TBL] [Abstract][Full Text] [Related]
10. Is the amorphous fraction of a dried nanosuspension caused by milling or by drying? A case study with Naproxen and Cinnarizine.
Kayaert P; Van den Mooter G
Eur J Pharm Biopharm; 2012 Aug; 81(3):650-6. PubMed ID: 22579733
[TBL] [Abstract][Full Text] [Related]
11. Continuous production of drug nanoparticle suspensions via wet stirred media milling: a fresh look at the Rehbinder effect.
Monteiro A; Afolabi A; Bilgili E
Drug Dev Ind Pharm; 2013 Feb; 39(2):266-83. PubMed ID: 22503097
[TBL] [Abstract][Full Text] [Related]
12. A microhydrodynamic rationale for selection of bead size in preparation of drug nanosuspensions via wet stirred media milling.
Li M; Alvarez P; Bilgili E
Int J Pharm; 2017 May; 524(1-2):178-192. PubMed ID: 28380391
[TBL] [Abstract][Full Text] [Related]
13. Is the combination of cellulosic polymers and anionic surfactants a good strategy for ensuring physical stability of BCS Class II drug nanosuspensions?
Bilgili E; Li M; Afolabi A
Pharm Dev Technol; 2016; 21(4):499-510. PubMed ID: 25774989
[TBL] [Abstract][Full Text] [Related]
14. Nanosizing of a poorly soluble drug: technique optimization, factorial analysis, and pharmacokinetic study in healthy human volunteers.
Elsayed I; Abdelbary AA; Elshafeey AH
Int J Nanomedicine; 2014; 9():2943-53. PubMed ID: 24971006
[TBL] [Abstract][Full Text] [Related]
15. Effect of arginine hydrochloride and hydroxypropyl cellulose as stabilizers on the physical stability of high drug loading nanosuspensions of a poorly soluble compound.
Ain-Ai A; Gupta PK
Int J Pharm; 2008 Mar; 351(1-2):282-8. PubMed ID: 18036751
[TBL] [Abstract][Full Text] [Related]
16. Development of agomelatine nanocomposite formulations by wet media milling.
Vardaka E; Andreas O; Nikolakakis I; Kachrimanis K
Eur J Pharm Sci; 2021 Nov; 166():105979. PubMed ID: 34425232
[TBL] [Abstract][Full Text] [Related]
17. Increased dissolution and physical stability of micronized nifedipine particles encapsulated with a biocompatible polymer and surfactants in a wet ball milling process.
Li N; DeGennaro MD; Liebenberg W; Tiedt LR; Zahr AS; Pishko MV; de Villiers MM
Pharmazie; 2006 Jul; 61(7):595-603. PubMed ID: 16889066
[TBL] [Abstract][Full Text] [Related]
18. Redispersible fast dissolving nanocomposite microparticles of poorly water-soluble drugs.
Bhakay A; Azad M; Bilgili E; Dave R
Int J Pharm; 2014 Jan; 461(1-2):367-79. PubMed ID: 24333905
[TBL] [Abstract][Full Text] [Related]
19. Process parameter dependent growth phenomena of naproxen nanosuspension manufactured by wet media milling.
Bitterlich A; Laabs C; Krautstrunk I; Dengler M; Juhnke M; Grandeury A; Bunjes H; Kwade A
Eur J Pharm Biopharm; 2015 May; 92():171-9. PubMed ID: 25766272
[TBL] [Abstract][Full Text] [Related]
20. The Impact of Process and Formulation Parameters on the Fabrication of Efavirenz Nanosuspension to Improve Drug Solubility and Dissolution.
Rashed M; Dadashzadeh S; Bolourchian N
Iran J Pharm Res; 2022 Dec; 21(1):e129409. PubMed ID: 36942076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
